2seventy bio Inc (TSVT)
4.375
-0.62
(-12.50%)
USD |
NASDAQ |
May 20, 15:02
2seventy bio Accounts Receivable (Quarterly): 11.98M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.98M |
| December 31, 2023 | 13.41M |
| September 30, 2023 | 19.52M |
| June 30, 2023 | 44.10M |
| March 31, 2023 | 41.25M |
| December 31, 2022 | 20.96M |
| September 30, 2022 | 12.04M |
| Date | Value |
|---|---|
| June 30, 2022 | 12.16M |
| March 31, 2022 | 16.93M |
| December 31, 2021 | 17.00M |
| September 30, 2021 | 16.14M |
| June 30, 2021 | 11.37M |
| December 31, 2020 | 10.69M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
10.69M
Minimum
Dec 2020
44.10M
Maximum
Jun 2023
19.04M
Average
16.14M
Median
Sep 2021
Accounts Receivable (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 8.826B |
| Johnson & Johnson | 14.95B |
| Macrogenics Inc | 7.219M |
| Akebia Therapeutics Inc | 26.62M |
| Tango Therapeutics Inc | -- |